Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Neutral

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Chimerix, Inc. (CMRX)

Pharmaceutical Preparations

https://www.chimerix.com

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment namely pharmaceuticals.

2505 MERIDIAN PARKWAY, SUITE 100
DURHAM, NC

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/11/2013

Market Cap

83,363,898

Shares Outstanding

88,890,000

Weighted SO

88,891,300

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

ASMB --.--%

SPRO --.--%

ACHL --.--%

TIL --.--%

NLTX --.--%

CTMX --.--%

NXTC --.--%

DAWN --.--%

XFOR --.--%

Beta

1.1940

Last Div

0.0000

Range

0.75-1.3

Chg

0.0949

Avg Vol

249253

Mkt Cap

83363898

Exch

NASDAQ

Country

US

Phone

919 806 1074

DCF Diff

0.6001

DCF

0.2767

Div Yield

0.0000

P/S

578.9160

EV Multiple

-0.7310

P/FV

0.5358

Div Yield %

0.0000

P/E

-0.9841

PEG

0.0067

Payout

0.0000

Current Ratio

6.9430

Quick Ratio

6.9430

Cash Ratio

0.7084

DSO

326.9792

DIO

0.0000

Op Cycle

326.9792

DPO

41.1330

CCC

285.8461

Gross Margin

-255.5347

Op Margin

-657.7847

Pretax Margin

-588.2014

Net Margin

-588.2014

Eff Tax Rate

0.0001

ROA

-0.4745

ROE

-0.4635

ROCE

-0.6056

NI/EBT

1.0000

EBT/EBIT

0.8942

EBIT/Rev

-657.7847

Debt Ratio

0.0038

D/E

0.0044

LT Debt/Cap

0.0000

Total Debt/Cap

0.0044

Int Coverage

-33.2822

CF/Debt

-99.8147

Equity Multi

1.1474

Rec Turnover

1.1163

Pay Turnover

8.8736

Inv Turnover

0.0000

FA Turnover

0.0961

Asset Turnover

0.0008

OCF/Share

-0.7573

FCF/Share

-1.0717

Cash/Share

1.6531

OCF/Sales

-471.3472

FCF/OCF

1.4152

CF Coverage

-99.8147

ST Coverage

-99.8147

CapEx Coverage

-2.4084

Div&CapEx Cov

-2.4084

P/BV

0.5358

P/B

0.5358

P/S

578.9160

P/E

-0.9841

P/FCF

-0.8679

P/OCF

-1.2281

P/CF

-1.2281

PEG

0.0067

P/S

578.9160

EV Multiple

-0.7310

P/FV

0.5358

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Mar 08, 21:23 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VOXX, CMRX, WBA, ML on Behalf of Shareholders GlobeNewswire Inc. Oct 18, 20:31 Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Dec 29, 07:00 Chimerix Appoints Lisa Decker to Board of Directors GlobeNewswire Inc. Nov 24, 07:00 Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Revenue Product Segmentation